Viewing Study NCT05132569


Ignite Creation Date: 2025-12-24 @ 11:14 PM
Ignite Modification Date: 2025-12-25 @ 8:50 PM
Study NCT ID: NCT05132569
Status: TERMINATED
Last Update Posted: 2025-09-09
First Post: 2021-11-12
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Efficacy and Safety of Tolebrutinib (SAR442168) Tablets in Adult Participants With Generalized Myasthenia Gravis
Sponsor: Sanofi
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2021-12-03
Start Date Type: ACTUAL
Primary Completion Date: 2023-02-21
Primary Completion Date Type: ACTUAL
Completion Date: 2023-02-21
Completion Date Type: ACTUAL
First Submit Date: 2021-11-12
First Submit QC Date: None
Study First Post Date: 2021-11-24
Study First Post Date Type: ACTUAL
Results First Submit Date: 2024-02-15
Results First Submit QC Date: None
Results First Post Date: 2024-04-08
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-09-08
Last Update Post Date: 2025-09-09
Last Update Post Date Type: ESTIMATED